耐药性:定义,病理生理学和管理
Boulenouar Mesraoua1, Francesco Brigo2, Simona Lattanzi3
1Neurosciences Department, Hamad Medical Corporation and Weill Cornell Medical College, Doha, Qatar.
Journal of the neurological sciences
|August 19, 2023
概括
耐药性 (DRE) 影响全球三分之一的患者 (PWE). 本综述定义了DRE,探讨了其生物基础和生物标志物,并提出了更好的押控制的管理策略.
科学领域:
- 神经学 神经学
- 临床医学 临床医学
- 药理学 药理学是指药理学的学科.
背景情况:
- 影响全球超过5100万人,每年有近490万例新发病例.
- 抗发作药物 (ASM) 是患者的主要治疗方法.
- 大约三分之一的PWE患有耐药性 (DRE),未能通过ASM控制发作.
研究的目的:
- 为了定义耐药性 (DRE).
- 阐明与DRE相关的生物学基础和临床生物标志物.
- 为DRE.提出实际的管理策略.
主要方法:
- 这项研究是一篇叙事性综述.
- 关于DRE定义,病理生理学,生物标志物和治疗的文献搜索.
- 综合当前的知识和临床指南.
主要成果:
- 耐药性 (DRE) 的特点是,尽管对两个或两个以上的ASM进行了充分的试验,但仍有持续的发作.
- 生物因素和特定的临床生物标志物有助于理解和潜在的预测DRE.
- 基于证据的管理策略可以改善DRE患者的结果.
结论:
- 准确的定义和对DRE的理解对于有效的患者护理至关重要.
- 识别生物标志物可能有助于早期诊断和个性化治疗方法DRE.
- 实施有针对性的管理策略至关重要,以改善患有DRE的PWE的控制和生活质量.
相关概念视频
Arteries of the Lower Limbs
213
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
213
Antiepileptic Drugs: Sodium Channel Blockers
664
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
664
Antiepileptic Drugs: Glutamate Antagonists
421
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
421
Antiepileptic Drugs: GABAergic Pathway Potentiators
460
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
460
Antiepileptic Drugs: Potassium Channel Activators
211
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
211
Antiepileptic Drugs: Calcium Channel Blockers
453
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
453


